An optimized peptide blend consisting of the pentadecapeptide BPC-157 and the synthetic fraction of thymosin beta-4 (TB-500). Developed to allow researchers to study concurrent cellular signaling mechanisms, systemic tissue response protocols, and compound interaction matrices within modern biochemical environments.